XML 95 R81.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT INFORMATION - Segment Information Of Net Sales And Operating Income (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]    
Net sales $ 2,625 $ 2,490
Cost of sales 1,764 1,529
Selling, general and administrative expenses 703 729
Research and development expenses 140 120
Operating income 58 115
Operating Segments | Medical Products & Therapies    
Segment Reporting Information [Line Items]    
Net sales 1,262 1,229
Cost of sales 694 668
Selling, general and administrative expenses 286 284
Research and development expenses 59 52
Other segment items (21) (2)
Operating income 244 227
Operating Segments | Healthcare Systems & Technologies    
Segment Reporting Information [Line Items]    
Net sales 704 667
Cost of sales 356 346
Selling, general and administrative expenses 217 207
Research and development expenses 45 47
Other segment items (7) 0
Operating income 93 67
Operating Segments | Pharmaceuticals    
Segment Reporting Information [Line Items]    
Net sales 581 578
Cost of sales 396 382
Selling, general and administrative expenses 103 96
Research and development expenses 26 22
Other segment items (7) 0
Operating income $ 63 $ 78